Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$5.72 - $10.65 $6,864 - $12,780
-1,200 Closed
0 $0
Q4 2021

Feb 09, 2022

SELL
$12.99 - $17.73 $23,187 - $31,648
-1,785 Reduced 59.8%
1,200 $17,000
Q3 2021

Nov 12, 2021

BUY
$14.85 - $21.34 $32,670 - $46,948
2,200 Added 280.25%
2,985 $59,000
Q1 2021

May 13, 2021

BUY
$23.29 - $53.2 $18,282 - $41,762
785 New
785 $27,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Evoke Wealth, LLC Portfolio

Follow Evoke Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evoke Wealth, LLC with notifications on news.